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The light chains of mouse Igs have been classified into two isotypes, K and X.
In contrast to the x chains, the A chains were shown to display restricted
heterogeneity. Two V.1 gene segments and four J.1-CA gene pairs have been
described (1). The three X subtypes (X1, X2, and a3) are respectively encoded by
the combination of VA1J.11-C.11, VA2J.12-CA2, and V.11JA3-C.13 gene segments.
The J.14-C.14 gene pair was never found to be functional (2, 3). In the mouse,
study of the X-bearing Igs is made difficult by the fact that they represent only
5% of total Igs (4). Three strategies were described to increase their level in
sera. The first method consisted in immunizing mice with antigens that are
known to elicit X+ immune responses (5). The second method consisted in
producing rc-immunosuppressed mice by repeated injections of anticc antibodies
(6). We have previously described a third method, which is to inject mice with
anti-X antibodies coupled to LPS (7, 8). In this paper we describe BALB/c
hybridomas obtained after injection with anti-X2 antibodies coupled to LPS and
demonstrate the existence of an unexpected new X light chain.
Materials and Methods
Radioimmunoassays.
￿
In this study, five inhibition assays were used to characterize the
isotype of the murine Ig light chain. Each system was carried out as follows: Anti-u/rc assay
was carried out by the inhibition of the fixation of "'I-rabbit anti-u to 48-9 ('y,K) murine
monoclonal Ig. The anti-K antibodies were isolated from an anti-MOPC 460 (a,K) anti-
serum on an XRPC24 (a,K) Sepharose-AH column. Anti-X1/al assay was carried out by
the inhibition of the fixation of 12'I-rabbit anti-X1 to TNP 15 (la,XI) murine monoclonal
Ig. The anti-X1 antibodies were isolated from an antiJ558 (a,XI) antiserum previously
absorbed on an HO-2 .2 (ta,K) column, on a BI-8 (,u,X l) column. Anti-X2/X2 assay was
carried out by the inhibition of the fixation of '251-rabbit anti-A2 to TNP 9 (y,a2) murine
monoclonal Ig. The anti-X2 antibodies were isolated from an anti-MOPC 315 (a,Jt2)
antiserum repeatedly absorbed on a J558 (a,XI) column, on a MG8-13 (y,X2) column.
Anti-X2/X1 assay was carried out by the inhibition of the fixation of '25I-rabbit anti-X2
to TNP 5 (fc,XI) murine monoclonal Ig. The anti-a2 antibodies were isolated from an
anti-MOPC 315 (a,X2) antiserum on J558 (a,XI) column. Subsequently, the anti-a anti-
bodies were absorbed on a MOPC 460 (a,K) column. Anti-X1/X3 assay was carried out by
the inhibition of the fixation of 125I-rabbit anti-X1 to 1 .5F9 (y,a3) murine monoclonal
Ig. The anti-al antibodies were prepared as described above.
Isoelectric Focusing.
￿
Cells (8 x 106) were cultured for 30 min in 1 ml of minimum
medium, then 300,uCi of [sH]leucine were added for 3 h, after which the supernatants
were harvested. Supernatants (50-100 tal) were incubated with 12 tal of protein A-
Sepharose pretreated with 5 tal of rabbit anti-XI or anti-a2 immune serum. Half of the
immunoprecipitated material was deposited on a 6% acrylamide gel containing 0.1 % SDS.
After the migration (20 mA constant current), the band containing bromophenol blue
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was cut out (light chains migrate with the front) and deposited on a 4% acrylamide gel
with 8M urea andpH 5-8 ampholines . After migration (18 h at 400 V and 1 h at 1,000
V), the gel was fixedand then incubated with enhancer solution . After water washingand
drying, the gel was autoradiographed (1-wk exposure on Kodak X-Omat AR film) . For
more technical details see reference 9 .
Dot Blots. Cells (4 X 106) were washed twice in balanced salt solution (BSS) and
incubated at 4°C with 90 Al of wall buffer (0.01 M Tris HCI, pH 8.4; 0.14 M NaCl ; 1 .5
M MgCl2) plus 10 Al of Triton X-100 (10%) . After centrifugation, the supernatant was
mixed with 100,ul of2X proteinaseK buffer (0 .2M Tris HCI, pH 7.4, 0.3 M NaCl ; 0.025
M EDTA ; 2% SDS) plus 100 Ag of proteinase K and incubated for 30 min at 37°C .
Cytoplasmic RNA was extracted by the chloroform method . 440 'l of 20X SSC, 160 Al
of 37% formaldehyde, and 2001A1 of waterwere added to 80,ul of RNA solution . After a
15-min incubation at 60°C, 50 j,l of this preparation or successive dilutions were filtered
through a nitrocellulose filter. The RNA filters were hybridized with s2P-labeled DNA
probes (5-50 X 105 cpm/ml) in formamide hybridization buffer (50% formamide, 5X
SSC, 50 mM Na2PO4 , pH 6.5, 0.2% SDS, 5X Denhart's, 10 mg/ml of Salmon DNA) .
Hybridization was carried out at 42'C for 18 h and washing with 0.1X SSC, 0.1%SDS at
42'C . TheVX1 and the CX1 probes were 0.9-kb and 3.6-kb restriction fragments from
an Xba I digest of X1 DNA clones (10) . The CX2 probe wasa 200-bp restriction fragment
from Ava I and Pst I digest of the pXII-I insert (11) . The probes were generously given
by Dr . T.J. Kindt (National Institutes of Health, Bethesda, MD).
Nucleotide Sequencing.
￿
RNA was extracted from solidtumors by the LiCl-urea method
(12) and poly(A)'-mRNA was isolated on an oligo(dT)-cellulose column . The RNA
fractionscoding forheavy and light chains were separated on a sucrose gradient (5-20%) .
Experimental conditions for nucleotide sequencing by the method of Sanger et al . (13)
were described by Rocca-Serra (14) . The CX primer (dTCAGAGGAAGGTG) was syn-
thetized by the laboratory of Dr . Igolen (Institut Pasteur, Paris) .
Results and Discussion
Characterization ofXB Cell Clones .
￿
To obtain hybridomas secreting X-bearing
Igs, Sp2 .0 cells were fused with spleen cells from a BALB/c mouse pretreated 3
d before with rabbit anti-X2 antibodies coupled to LPS. We selected X-secreting
hybridomas (B hybridomas) using an anti-X2 mAb that did not recognize K or X1
light chains . As the anti-X2 antibody also reacted with the X3 chain (8), we
attempted to characterize the X2 or X3 subtype ofour hybridomas by biochemical
methods . Isoelectric focusing of [sH]leucine biosynthetically labeled light chain
was performed (Fig. 1) . In addition to the two expected isoelectric spectra for
the X2 and the X3 chains, a third isoelectric spectrum (group 111) could be
distinguished among the B hybridomas . Group I and group II corresponded,
respectively, to the X2 and X3 groups, as determined by SDS-PAGE analysis (not
shown) . The isoelectric spectrum of group III differed also from that of X 1
chains .
A New Variable Region .
￿
To characterize these groups serologically, we used
rabbit anti-X antibodies to either variable or constant regions of X chains (15) .
Since the homology of sequence between VX1 and VX2 or between CX2 and
CX3 regions, respectively, is more extensive (>90%) than the homology between
the CX1 and CX2 regions or between CX1 and CX3 (2, 10, 16, 17), anti-CX
antibodies can distinguish between X1 subtype, on one hand, and X2 or X3
subtypes,on theother. Anti-VXantibodies, however, will recognize all X subtypes .
Thus, we used four RIAs where the anti-X1/X1 and the anti-X2/X2 interactions,
which are more specific for CX regions, and the anti-X1/X3 and anti-X2/X1
interactions, which are more specific forVX regions, were inhibited by differentSANCHEZ AND CAZENAVE
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FIGURE 1 .
￿
Isoelectric focusing of A light chains . TNP5 (W,XI) and TNP9 (y3,a2) are two
BALB/c anti-TNP hybridomas. HybridomasB and D derived from a BALB/c mouse treated
with rabbit anti-a2 antibodies coupled to LPS (R anti-a2-LPS) . Hybridomas B were typed X
using an anti-a2 mAb that reacted with the X2 and X3 light chains. Hybridomas D were typed
A1 using an anti-al mAb that did not crossreact with X2 or a3 .
reagents . As shown in Table I, the hybridomas belonging to group III showed a
unique characteristic as compared with those of groups I and II and to XI
hybridomas . With theexception of the A I + cases, all culture supernatants strongly
inhibited the anti-X2/X2 interaction but not the anti-XI/XI interaction . In addi-
tion to this, all supernatants, except for those of group III, inhibited the anti-
XI/X3 and the anti-X2/XI interactions . These surprising results suggested that
the hybridomas of group III used a variable domain different from the two
known VX regions .
To confirm this hypothesis, cytoplasmic RNA was isolated from each a Ig-
secreting hybridoma and transferred to nitrocellulose filters . Hybridization with
VXI, CXI, and Ca2 probes was carried out (Fig . 2) . RNA of hybridomas
belonging to group III hybridized with the CX2 probe but not with CXI and
VXI probes . On the other hand, the Ca2 and the VXI probes did hybridize with
the RNA of the hybridomas of the a2 and the a3 subtypes . These results
confirmed that the light chains of the group III hybridomas were encoded by a
V gene segment that was distinct from the V.ll and VJ12 gene segments .
Since the CX2 probe hybridized to the RNA of the group III hybridomas, we
attempted to sequence the mRNA coding the light chain of the 136 hybridoma
belonging to the group III, using a CX primer that hybridized with the three C11
genes. The results presented in Fig. 3 demonstrate the existence ofa newVgene
segment. Indeed, the partial sequence of the B6 light chain was significantly
different from the knownV.11 and V.12 genomic sequences (55% ofhomology in268
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TABLE I
Serological Characteristics ofMouse a Chains
Hybridoms B and D derived from BALB/c mouse treated with R anti-k2-LPS (see legend of Fig. 1). Purified
monoclonal Igs 48-9 (y, K), TNP 15 (,u, al), M315 (a, a2), and 1.5F9 (,y, k3) were used as controls in these RIAs.
The inhibitor concentration of the purified protein was 5 lAg/ml for the anti-a2/A2 and anti-al/a3 systems and 625
ng/ml or the other systems.
the sequenced V segment). This hybridoma used the JA2 gene segment and
probably the C.12 gene segment. However, the sequence between the conserved
Cys at position 88 (TGT codon) and the beginning of theJA gene segment was
of unexpected length. Indeed, such a distance has never been described in
murine K or X light chains (18).
Thus, several lines of evidence demonstrate the existence of a new variable
segment used by the light chain of some X Igs in the mouse. This finding could
suggest the existence of other undescribed gene segments since it has already
been reported that, in wild mice, the X genes are more numerous than in the
domestic strains (19, 20).
Summary
A series of X+ murine hybridomas were derived from a BALB/c mouse after
a single injection of anti-X2 antibodies coupled to LPS. Nine X B cell clones (five
X2 and four X3) were expected and seven reacted with antibodies specific for the
Ca2 constant region but showed a particular isoelectric spectrum. Their RNA
products did not hybridize with the VX probe. The partial DNA sequence of
gene segments coding the unexpected light chain of one hybridoma shows that
the Vgene segment has only 55% homology with the VA2 gene segment sequence
Subtype Group
Supernatant of
hybridoma
culture
Percent inhibition of rabbit anti-light chain antibodies/mouse
light chain interactions
Anti-k/k Anti-al/X1 Anti-X2/X2 Anti-X2/al Anti-al/x3
a2 I B3 12 23 92 78 67
B9 20 18 92 80 70
B23 26 21 94 74 70
B31 15 25 85 55 70
B15 25 18 91 62 71
a3 II B25 10 35 63 67 97
B21 19 26 68 80 90
B16 20 32 71 86 96
B5 23 30 69 61 94
? III BS 21 0 73 6 0
B10 21 0 72 6 10
B11 27 0 79 14 2
B22 32 0 71 4 0
B24 28 3 76 9 3
B32 19 0 74 5 0
B6 14 0 75 3 0
al - DS 12 96 37 77 95
D9 25 97 26 75 96
Purified mono-
clonal Igs:
k 48-9 76 0 16 10 0
al TNP15 3 88 16 67 88
a2 M315 30 32 95 81 73
a3 1 .5F9 2 34 81 74 92SANCHEZ AND CAZENAVE BRIEF DEFINITIVE REPORT
I, CX1 and Cat probes .
and thatJ.12 and probably C.12 gene segments are used . Taken
results demonstrate the existence ofa new a light chain .
together, these
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FIGURE 3 . Partial DNA se-
quence of the new V gene seg-
ment compared with known ge-
nomicDNA sequences ofVAl and
V.12 gene segments . (X) Undeter-
mined nucleotide ; (-) Identical
nucleotide. Lowercase letters, nu-
cleotide determined once. Amino
acid numbering is according to
Kabat et al . (21) .'
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